Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > H.C. Wainwright on AEZS's diagnostic test:

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Jan 01, 2024 7:19pm

58 Views

Post# 35806385

RE:H.C. Wainwright on AEZS's diagnostic test:

"...it is safe, is as accurate as standard insulin tolerance testing (ITT), and unlike ITT, it can prevent adult growth hormone deficiency overdiagnosis."

AEZS's test can prevent overdiagnosis. Could patient sue? Treating people when they don't need to be treated can also be costly.

Bing,

"Overdiagnosis of GHD can lead to unnecessary treatment with synthetic growth hormone, which can cause side effects such as joint pain, muscle pain, swelling, and numbness. In addition, it can lead to increased healthcare costs and psychological distress for the patient and their family 2."

<< Previous

Bullboard Posts

Next >>

How to trade on the stock market: A beginner’s guide